Highbridge Capital Management LLC trimmed its stake in Smith & Nephew plc (NYSE:SNN) by 75.1% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 90,010 shares of the medical equipment provider’s stock after selling 272,190 shares during the period. Highbridge Capital Management LLC’s holdings in Smith & Nephew were worth $3,338,000 as of its most recent SEC filing.

A number of other large investors also recently made changes to their positions in SNN. Nuance Investments LLC grew its holdings in shares of Smith & Nephew by 30.5% during the third quarter. Nuance Investments LLC now owns 2,794,889 shares of the medical equipment provider’s stock worth $103,722,000 after purchasing an additional 653,488 shares during the last quarter. Glenmede Trust Co. NA grew its holdings in shares of Smith & Nephew by 22.4% during the second quarter. Glenmede Trust Co. NA now owns 981,568 shares of the medical equipment provider’s stock worth $36,838,000 after purchasing an additional 179,800 shares during the last quarter. Connor Clark & Lunn Investment Management Ltd. grew its holdings in shares of Smith & Nephew by 31.3% during the third quarter. Connor Clark & Lunn Investment Management Ltd. now owns 889,934 shares of the medical equipment provider’s stock worth $33,008,000 after purchasing an additional 211,919 shares during the last quarter. Northern Trust Corp grew its holdings in shares of Smith & Nephew by 1.0% during the second quarter. Northern Trust Corp now owns 689,297 shares of the medical equipment provider’s stock worth $25,870,000 after purchasing an additional 6,530 shares during the last quarter. Finally, Crossmark Global Holdings Inc. grew its holdings in shares of Smith & Nephew by 4.7% during the third quarter. Crossmark Global Holdings Inc. now owns 374,014 shares of the medical equipment provider’s stock worth $13,872,000 after purchasing an additional 16,923 shares during the last quarter. Hedge funds and other institutional investors own 9.03% of the company’s stock.

Several analysts have recently commented on SNN shares. Canaccord Genuity restated a “buy” rating on shares of Smith & Nephew in a report on Thursday, November 1st. Zacks Investment Research upgraded Smith & Nephew from a “hold” rating to a “buy” rating and set a $40.00 target price on the stock in a report on Wednesday, August 29th. Finally, HSBC cut Smith & Nephew from a “buy” rating to a “hold” rating in a report on Tuesday, October 16th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and three have issued a buy rating to the company’s stock. Smith & Nephew currently has a consensus rating of “Hold” and an average price target of $42.00.

Smith & Nephew stock opened at $37.21 on Friday. Smith & Nephew plc has a 12-month low of $32.22 and a 12-month high of $39.85. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.05 and a current ratio of 2.13.

WARNING: This report was first posted by Watch List News and is owned by of Watch List News. If you are reading this report on another website, it was copied illegally and reposted in violation of US & international copyright and trademark law. The original version of this report can be accessed at https://www.watchlistnews.com/highbridge-capital-management-llc-has-3-34-million-holdings-in-smith-nephew-plc-snn/2666989.html.

About Smith & Nephew

Smith & Nephew plc designs, develops, and sells medical devices worldwide. The company offers sports medicine joint repair products for surgeons, including an array of instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the knee, hip, and shoulder.

Read More: Correction

Want to see what other hedge funds are holding SNN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Smith & Nephew plc (NYSE:SNN).

Institutional Ownership by Quarter for Smith & Nephew (NYSE:SNN)

Receive News & Ratings for Smith & Nephew Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew and related companies with MarketBeat.com's FREE daily email newsletter.